Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03795805Completed
Randomised, double-blind trial of lidocaine in knee osteoarthritis (OA) (2 arms), sponsored by Instituto Mexicano del Seguro Social. Primary endpoints: Serum Creatinine at 48 hours and Acute Kidney Injury Incidence at 48 hours. Started Mar 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03795805.